WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
WhiteLab Genomics's investors include Y Combinator, Omnes Capital, Debiopharm Group.
WhiteLab Genomics is headquartered in Paris, France.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
WhiteLab Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"WhiteLab Genomics — Funding & Investors." VCBacked, September 12, 2022, https://www.vcbacked.co/company/whitelab-genomics. Accessed August 14, 2026.
VCBacked. (2022). WhiteLab Genomics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/whitelab-genomics
{{cite web |title=WhiteLab Genomics — Funding & Investors |url=https://www.vcbacked.co/company/whitelab-genomics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated